Please use this identifier to cite or link to this item: https://doi.org/10.1186/s13287-019-1451-2
DC FieldValue
dc.titleApplications of miRNAs in cardiac development, disease progression and regeneration
dc.contributor.authorPang, J.K.S.
dc.contributor.authorPhua, Q.H.
dc.contributor.authorSoh, B.-S.
dc.date.accessioned2021-12-29T04:31:46Z
dc.date.available2021-12-29T04:31:46Z
dc.date.issued2019
dc.identifier.citationPang, J.K.S., Phua, Q.H., Soh, B.-S. (2019). Applications of miRNAs in cardiac development, disease progression and regeneration. Stem Cell Research and Therapy 10 (1) : 336. ScholarBank@NUS Repository. https://doi.org/10.1186/s13287-019-1451-2
dc.identifier.issn17576512
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/212258
dc.description.abstractDevelopment of the complex human heart is tightly regulated at multiple levels, maintaining multipotency and proliferative state in the embryonic cardiovascular progenitors and thereafter suppressing progenitor characteristics to allow for terminal differentiation and maturation. Small regulatory microRNAs (miRNAs) are at the level of post-transcriptional gene suppressors, which enhance the degradation or decay of their target protein-coding mRNAs. These miRNAs are known to play roles in a large number of biological events, cardiovascular development being no exception. A number of critical cardiac-specific miRNAs have been identified, of which structural developmental defects have been linked to dysregulation of miRNAs in the proliferating cardiac stem cells. These miRNAs present in the stem cell niche are lost when the cardiac progenitors terminally differentiate, resulting in the postnatal mitotic arrest of the heart. Therapeutic applications of these miRNAs extend to the realm of heart failure, whereby the death of heart cells in the ageing heart cannot be replaced due to the arrest of cell division. By utilizing miRNA therapy to control cell cycling, the regenerative potential of matured myocardium can be restored. This review will address the various cardiac progenitor-related miRNAs that control the development and proliferative potential of the heart. © 2019 The Author(s).
dc.publisherBioMed Central Ltd.
dc.rightsAttribution 4.0 International
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2019
dc.subjectCardiac development
dc.subjectCardiac regeneration and development
dc.subjectCardiovascular progenitors
dc.subjectMicroRNA
dc.subjectStem cell niche
dc.typeReview
dc.contributor.departmentDEPT OF BIOLOGICAL SCIENCES
dc.description.doi10.1186/s13287-019-1451-2
dc.description.sourcetitleStem Cell Research and Therapy
dc.description.volume10
dc.description.issue1
dc.description.page336
Appears in Collections:Staff Publications
Elements

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_1186_s13287-019-1451-2.pdf681.26 kBAdobe PDF

OPEN

NoneView/Download

SCOPUSTM   
Citations

22
checked on Nov 24, 2022

Page view(s)

78
checked on Dec 1, 2022

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons